ORAL IDARUBICIN IN NON-HODGKINS-LYMPHOMAS

被引：23

作者：

LOPEZ, M

DILAURO, L

PAPALDO, P

机构：

来源：

关键词：

D O I：

10.1007/BF00179594

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：263 / 267

页数：5

共 10 条

[1]

[Anonymous], 1982, CANCER, V49, P2112

[2]

ARCAMONE F, 1976, CANCER TREAT REP, V60, P829

[3]

BENDER RA, 1978, RANDOMIZED TRIALS CA, P77

[4]

Bonfante V, 1983, Invest New Drugs, V1, P161

[5]

COONLEY JC, 1983, CANCER TREAT REP, V67, P949

[6]

GIULIANI FC, 1983, ANTHRACYCLINES CANC, P193

[7]

KAPLAN S, 1984, INVEST NEW DRUG, V2, P281

[8] EPIRUBICIN IN NON-HODGKINS LYMPHOMAS [J].

LOPEZ, M ;

DILAURO, L ;

GANZINA, F ;

PERNO, CF ;

PAPALDO, P ;

DIPIETRO, N .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (02) :151-153

[9]

MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO

[10]

2-6